Thank you for your interest in clinical trials for SpasticityPlease click "Search" to find Spasticity clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned no results. Get alerts when studies become available.
Your search returned 13 studies. (Get alerts for new studies):Screening and Natural History: Primary Lateral Sclerosis and Related DisordersConditions: Motor Nueron Disease - Nervous System Diseases - Muscle Spasticity - Diffusion Tensor Imaging - Disease Progression - Evoked Potentials, Motor/Physiology1 Location availableSISTERS: Spasticity In Stroke Study - Randomized StudyConditions: Severe Spasticity3 Locations availableDysport® Adult Lower Limb Spasticity StudyConditions: Leg Spasticity8 Locations availableDysport® Pediatric Lower Limb Spasticity Follow-on StudyConditions: Cerebral Palsy - Muscle Spasticity - Children1 Location availableCannabis for Spasticity in Multiple SclerosisConditions: Multiple Sclerosis1 Location availableDysport® Adult Upper Limb SpasticityConditions: Nervous System Disorders6 Locations availableExploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human MuscleConditions: Stroke - Muscle Spasticity1 Location availableDysport® Pediatric Lower Limb Spasticity StudyConditions: Cerebral Palsy - Muscle Spasticity - Children5 Locations availableEnergy Costs of Spasticity in Spinal Cord Injury: A Pilot InvestigationConditions: Basal Energy Expenditure - Spasticity1 Location availableOptical Stimulation Rhizotomy StudyConditions: Muscle Spasticity1 Location availableEfficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a StrokeConditions: Post-stroke Spasticity of the Lower Limb.4 Locations availableEfficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple SclerosisConditions: Multiple Sclerosis26 Locations availableArbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)Conditions: Multiple Sclerosis21 Locations available
Didn't find what you were looking for? Try these alternatives: